General presentation of Tilray
We now invite you to learn a little more about the Tilray company and its economic environment. We will present to you in detail this company and its sources of income with its main activities and the various products which it markets as well as the markets on which it exercises.
The Tilray Inc group is a Canadian company specialized in the pharmaceutical sector and which more specifically offers cannabis-based products to pharmaceutical distributors. As such, the Tilray company carries out medical research on cannabis, cultivation of cannabis, and further processing and marketing of cannabis products worldwide.
Tilray also has a subsidiary called FHF Holdings Ltd which manufactures, markets and distributes consumer hemp products. Among the products in this company's portfolio are hemp heart, hemp oil, hemp granola, hemp protein powder and hemp milk. The company also markets cannabis to patients in certain countries around the world through subsidiaries located in Australia, Canada and Germany. The group's medical cannabis is produced in Canada and Europe. To date, the Tilray group employs nearly 1,646 people.
Regarding the distribution of turnover by type of product, we find at the top the sale of pure cannabis with 49.6% of turnover, the sale of hemp products for 35.8% of turnover, the sale of extracts cannabis for 14.5% of turnover and the sale of accessories and other products for 0.2% of turnover.
Finally, with regard to the geographic distribution of the group's revenues, we note that 78% comes from Canada, 14.1% from the United States and 7.9% from the rest of the world.
76.4% of retail investor accounts lose money when trading CFDs with this provider. Trade CFDs with Plus500